Serum levels of adipokines in obstructive sleep apnea Source: International Congress 2015 – Monitoring sleep-disordered breathing in children and adults Year: 2015
Frequency and predictors of obesity hypoventilation syndrome in morbidly obese (BMI ≥40) patients with obstructive sleep apnea syndrome Source: Annual Congress 2013 –Sleep disordered breathing in special situations II Year: 2013
Serum omentin levels in patients with obstructive sleep apnea syndrome Source: Annual Congress 2013 –Sleep disordered breathing in special situations I Year: 2013
Obstructive sleep apnea syndrome in obese patients: adiponectin levels Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005
Serum YKL-40 level is associated with apnea hypopnea index in patients with obstructive sleep apnea syndrome Source: International Congress 2014 – Of mice and men: physiology and biology of sleep disordered breathing Year: 2014
Does the neutrophil-to-lymphocyte ratio have any importance between subjects with obstructive sleep apnea syndrome with obesity and without obesity? Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016
Relationship between obstructive sleep apnea syndrome, plasma homocysteine levels and cardiovascular risk Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013
Daytime sleepiness in patients with obstructive sleep apnoea syndrome and its correlation to insulin resistance Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities Year: 2016
Correlation between amount of epicardial fat and A-FABP level in patients with obstructive sleep apnea Source: International Congress 2014 – Sleep disordered breathing 2 Year: 2014
Prevalence of sleep apnea syndrome in morbidly obese patients Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013
Gender differences in obstructive sleep apnea syndrome Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults II: questionnaires, epidemiology and sleep studies Year: 2015
Progression of subclinical atherosclerosis in obstructive sleep apnoea (OSA) Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016
Predictors of nocturnal hypertension in obstructive sleep apnea patients with metabolic syndrome Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013
Resistant hypertension and obstructive sleep apnea Source: Annual Congress 2013 –Sleep disordered breathing in special situations I Year: 2013
Determinant factors of serum leptin levels in patients with obstructive sleep apnea Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005
Relationship between echocardiographic assessment and plasma endothelin-1 levels in obese patients with or without obstructive sleep apnea Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015
Transition from obstructive sleep apnea (OSA) to obesity hypoventilation syndrome (OHS) Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies Year: 2015
Impact of obstructive sleep apnoea (OSA) on glucose metabolism Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007
Protective cardiovascular effect of sleep apnea severity in obesity hypoventilation syndrome Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016
The impact of CPAP on circulating IGF-1 in patients with OSAS Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation Year: 2016